Extended Course of Paxlovid May Help Some Patients With Long COVID
Some patients treated with prolonged courses of oral nirmatrelvir/ritonavir experienced long COVID symptom improvements, while others reported little to no changes in their symptoms.
Related Articles
#patientcare #physician #pharmacist #nationalpharmacistday | Pharmacy Times
In modern healthcare, true impact comes from collaboration. Pharmacists are more than medication experts – they’re essential partners elevating patient care…
#patientcare #physician #pharmacist #nationalpharmacistday | Pharmacy Times
In modern healthcare, true impact comes from collaboration. Pharmacists are more than medication experts – they’re essential partners elevating patient care…
FDA Grants Fast Trask Designation to Invikafusp Alfa for Advanced Colorectal Cancer
Invikafusp alfa (STAR0602; Marengo Therapeutics Inc) is being investigated as a treatment for advanced colorectal cancer with high tumor mutational burden.
ACP Hospitalist
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
Using a novel smartphone app to track noise and vibration exposure during neonatal ambulance transport
Objective To assess the utility of a bespoke smartphone app to map noise and vibration exposure across neonatal road ambulance journeys. Design and setting Prospective…
See the Harm | NEJM
Medical students are faced with a dilemma: for them to learn, enough people have to get sick, with varied and sometimes terrible illnesses. In order…
AI Improves Breast Cancer Screening and Detection Rates in Real-World Study
Inclusion of AI improved detection and reduced instances of false-positive test results.
ACP Advocate | ACP Online
The ACP Advocate is a bi-weekly e-newsletter that provides ACP members with news about public policy issues affecting internal medicine.
Genomics | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
